Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Iron-mediated oxidative stress is implicated in the pathogenesis of renal ischemia-reperfusion injury. Hepcidin is an endogenous acute phase hepatic hormone that prevents iron export from cells by inducing degradation of the only known iron export protein, ferroportin. In this study, we used a mouse model to investigate the effect of renal ischemia-reperfusion injury on systemic iron homeostasis and determine if dynamic modulation of iron homeostasis with hepcidin has therapeutic benefit in the treatment of AKI. Renal ischemia-reperfusion injury induced hepatosplenic iron export through increased ferroportin expression, which resulted in hepatosplenic iron depletion and an increase in serum and kidney nonheme iron levels. Exogenous hepcidin treatment prevented renal ischemia-reperfusion-induced changes in iron homeostasis. Hepcidin also decreased kidney ferroportin expression and increased the expression of cytoprotective H-ferritin. Hepcidin-induced restoration of iron homeostasis was accompanied by a significant reduction in ischemia-reperfusion-induced tubular injury, apoptosis, renal oxidative stress, and inflammatory cell infiltration. Hepcidin -: deficient mice demonstrated increased susceptibility to ischemia-reperfusion injury compared with wild-type mice. Reconstituting hepcidin-deficient mice with exogenous hepcidin induced hepatic iron sequestration, attenuated the reduction in renal H-ferritin and reduced renal oxidative stress, apoptosis, inflammation, and tubula…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, a recent study showed that exogenous hepcidin is protective against renal ischaemia–reperfusion injury and oxidative stress, and that hepcidin deficiency exacerbates these forms of injury32.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [32]
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Reactive species mechanisms of cellular hypoxia-reoxygenation injury
Li, C., & Jackson, R. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2001 · Cited by 1,043
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Apoptosis and acute kidney injury
Havasi, A., & Borkan, S. C. (2011) · Kidney International · doi:10.1038/ki.2011.120 · Cited by 653
Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin
Mishra, J., Mori, K., Ma, Q., Kelly, C., Yang, J., Mitsnefes, M., Barasch, J., & Devarajan, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145013.44578.45 · Cited by 536
Cited by
Items 101–128 of 128
Zhao, L., Yang, X., Zhang, S., & Zhou, X. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2201362 · Cited by 11
The Effect of Hepcidin on Cardiac Ischemia-Reperfusion Injury
Bayraktar, A., Erbaş, D., Dizakar, S. Ö. A., Göktaş, T., Omeroglu, S., & Oz-Oyar, E. (2020) · Journal of investigative surgery · doi:10.1080/08941939.2019.1579275 · Cited by 7
Małyszko, J., Bachórzewska-Gajewska, H., Małyszko, J. S., Koc‐Żórawska, E., Matuszkiewicz‐Rowińska, J., & Dobrzycki, S. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.12.008 · Cited by 9
Iron, hormesis, and protection in acute kidney injury
Swaminathan, S. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.035 · Cited by 7
Self-citationPan, J., Yu, Q.-W., Song, Y.-D., Cui, Z.-C., He, Q.-Q., Cui, M.-W., Mei, C.-P., Cui, H.-N., Wang, H., Li, H., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202301445rr · Cited by 6
“27 HDAC6 is vital for both apoptosis and inflammation, although its function and mechanism in liver IRI remains poorly understood.”
BackgroundYu, X., Ma, X., Lyu, J., Jiang, N., Lu, Y., Liao, Y., Wang, K., & Yu, W. (2022) · Neuroreport · doi:10.1097/wnr.0000000000001836 · Cited by 6
Angiogenesis Markers and Recovery From Acute Kidney Injury: A Piece of the Puzzle?
Bouchard, J., & Mehta, R. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.03.421 · Cited by 6
Kurokawa, M., Nishiyama, K., Koga, Y., Eguchi, K., Imai, T., Oba, U., Shiraishi, A., Nagata, H., Kaku, N., Ishimura, M., et al. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04619-y · Cited by 6
Role of Iron Metabolic Disturbances and Inflammatory Iron Biomarkers in Liver Transplant Prognosis
Yu, L., Xu, J., Que, T., Miao, Z. H., Zhou, Y., Que, S., Zheng, S., & Liu, Z. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.113479 · Cited by 4
“Under normal circumstances, hepcidin is mainly synthesized in the liver and binds to ferroportin on the cell membrane, promoting its internalization and degradation, thereby reducing the release of intracellular iron[52].”
Olinder, J., Stjernqvist, M. J., Lindén, A., Salomonsson, E. T., Annborn, M., Herwald, H., & Rydèn, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299257 · Cited by 6
Oxidant‐ induced preconditioning: A pharmacologic approach for triggering renal ‘self defense’
Zager, R. (2022) · Physiological Reports · doi:10.14814/phy2.15507 · Cited by 4
Song, Y.-J., Zhang, Q.-Y., Wang, L., Cai, M.-C., Bao, J., & Yu, Q. (2022) · Bioengineered · doi:10.1080/21655979.2022.2073144 · Cited by 4
“Many experiments have confirmed the potential relationship between ferroptosis and AKI [9,27,28] and proposed that ferroptosis is expected to become an effective therapeutic target in diseases related to renal tubular necrosis.”
RetractedIron Inhibits the Translation and Activity of the Renal Epithelial Sodium Channel
Alli, A. A., Yu, L., Wlazlo, E., Kasem, S., Gholam, M. F., Desai, D. N., Lugo, C. I., Vaulont, S., & Scindia, Y. M. (2022) · Biology · doi:10.3390/biology11010123 · Cited by 5
“Hamp-/- mice are a well-established animal model that, under normal dietary conditions, accumulate iron in multiple organs including the kidneys [26,31] As shown above, these mice accumulate iron mostly in the renal tubules.”
BackgroundSelf-citationSystemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology
Vela, D. (2018) · BioFactors · doi:10.1002/biof.1468 · Cited by 5
“Finally, studies show that hepcidin might affect renal iron metabolism independently from FPN [21,37,42].”
BackgroundInfluentialEffects of Peptides and Bioactive Peptides on Acute Kidney Injury: A Review Study
Yarijani, Z. M., & Najafi, H. (2025) · Iranian Biomedical Journal · doi:10.61186/ibj.5000 · Cited by 3
Pei, J., Zhang, J., Yu, C., Luo, J., Wen, S., Hua, Y., & Wei, G. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101640 · Cited by 3
“27 Shan et al., on the other hand, found that allicin could improve renal IRI by inhibiting the inflammatory response in rats.”
Liu, L., Liu, Z.-R., Xiao, Y., Xiao, J.-H., Huang, W., Liu, W.-Y., Zhao, K., & Ye, Y.-J. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112103 · Cited by 9
Zhu, Y., Liu, Y., Wang, H.-C., Geng, Z., Kan, Y., Cao, X., & Yan, X. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03688-0 · Cited by 1
“Scindia et al. demonstrated in a murine ischaemia–reperfusion injury model that elevated serum hepcidin confers renoprotection, and exogenous hepcidin administration restores iron homeostasis and attenuates renal injury [19, 37, 38].”
Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury
Annamalai, C., Ganesh, R. N., & Viswanathan, P. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220946271 · Cited by 5
“This probably is due to renal hypoxia resulting from iohexol-induced renal vasoconstriction and ischemia.47,48 Hepcidin is a negative regulator of intestinal iron absorption and iron release from macrophages, by inactivating the iron export protein ferroportin.49,50 Hepcidin expression is induced by iron storage and i…”
BackgroundKhalifa, A., & Ghoneim, M. (2018) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v3i1.rw1 · Cited by 2
Socio-economic status, iron deficiency anemia and COVID-19 disease burden – an appraisal
Ghosh, K., Chatterjee, D., Roy, A. G., Anthropological Survey of India, C. R., & Bandyopadhyay, A. R. (2021) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2021.1.8 · Cited by 3
Iron and acute kidney injury: potential biomarkers for diagnosis and therapy
Shi, Z., Zhang, C., Yan, C., Tian, M., Zeng, X., Xie, T., Zhao, D., Zhou, X., Wu, Q., Zhang, S., et al. (2026) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgag119
Annamalai, C., & Viswanathan, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093802 · Cited by 1
“Evidence base: • [Preclinical] Hepcidin expression increases with systemic iron overload (liver upregulation) [125], and exogenous hepcidin or mimetics reduce the severity of ischemia–reperfusion and hemoglobin-mediated renal injury in rodent models [124,126].”
Wang, H., Li, P., Xiong, X., & Gao, Y. (2026) · Biochemical Genetics · doi:10.1007/s10528-026-11339-9
“In addition, PTPRC was significantly correlated with the development of hypoxic-ischemic brain injury and renal IR injury (Wen et al. 2024; Scindia et al. 2015).”
El-Toukhy, S. E., Fadel, F. I., Elshamaa, M. F., El-Saeed, G. S. M., Abdelaziz, H., El-Sonbaty, M. M., Elghoroury, E. A., Hamza, E., & Atef, S. N. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4268 · Cited by 1
“Iron binding effects in intra- and extracellular spaces of iron-chelating agents might be of benefit in renal injury [27].”
BackgroundBiomarkers of acute kidney injury and their role in clinical patient management
Değer, E. B., Arslan, E., Değer, M. D., & Kaya, O. (2020) · Biomedical Reviews · doi:10.14748/bmr.v31.7701 · Cited by 1
“This increase is thought to be a renoprotective response to reduce kidney damage (114-116).”
BackgroundElevated serum iron level is a predictor of prognosis in severe patients with acute kidney injury
Shu, J., Hu, Y.-F., Yu, X.-S., Chen, J., Xu, W.-W., & Pan, J.-Y. (2020) · doi:10.21203/rs.3.rs-23349/v1
“In terms of iron targeted therapy in AKI, the therapeutic effects of hepcidin, deferoxamine, apolipoprotein, pharmacologic therapy with apotransferrin and hydroxyl radical scavengers were reported in animal models [37, 38].”
BackgroundPharmacological Interventions in Acute Kidney Injury
Chopra, T., Balogun, R. A., & Okusa, M. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00048-3
Self-citation
Metadata
- Authors
- Scindia, Y., Dey, P., Thirunagari, A., Liping, H., Rosin, D. L., Floris, M., Okusa, M. D., & Swaminathan, S.
- Affiliations
- University of Virginia Health System (US)
- Azienda Ospedaliera G. Brotzu (IT)
- Corresponding author
- Scindia, Yogesh
- Dey, Paromita
- Thirunagari, Abhinav
- Liping, Huang
- Floris, Matteo
- Okusa, Mark D.
- Swaminathan, Sundararaman
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-11
- Volume
- 26
- Issue
- 11
- Pages
- 2800-2814
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4625680
- OpenAlex
- W2010431026
- Cited by
- 141
- References
- 0
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 13 · 2023: 17 · 2022: 15 · 2021: 12 · 2020: 17 · 2019: 18 · 2018: 15 · 2017: 6 · 2016: 9 · 2015: 3
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- University of Virginia
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hepcidin, renal ischemia-reperfusion injury, acute kidney injury, ferroportin, H-ferritin, oxidative stress, renal inflammation, interleukin-6, renal tubular injury, apoptosis
- MeSH terms
- Animals, Gene Expression Regulation, Homeostasis, Inflammation, Iron, Kidney, Male, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Fluorescence, Spleen, Reperfusion Injury, Interleukin-6, Apoptosis, Leukocyte Common Antigens, Oxidative Stress, In Situ Nick-End Labeling, Mice, Acute Kidney Injury, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.